EUVIMEDOpdag EUVIMED
Crossref

Design and Synthesis of Sulfonium and Selenonium Derivatives Bearing 3′,5′‐ O ‐Benzylidene Acetal Side Chains as Potent α ‐Glucosidase Inhibitors

Yaojia Li, Jiahui Zhou, Xiaoxing Wu, Wei Li, Zhe Wang, Jianchen Yang, Genzoh Tanabe, Osamu Muraoka, Weijia Xie iD

ChemMedChem · 2025

DOI: 10.1002/cmdc.202500299 ↗

At a glance

Journal article in ChemMedChem, 2025. Written by Yaojia Li and 8 co-authors. Institution: School of Medicinal Chemistry, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, 210009, P. R. China. Major MEDLINE topics: Glycoside Hydrolase Inhibitors, alpha-Glucosidases, Drug Design, Sulfonium Compounds. 52 references. Funded by: National Key R&D Program of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

A series of sulfonium, selenonium, and ammonium salts featuring diverse benzylidene acetal side chain substituents are designed and synthesized. In contrast to the previous work, this study emphasized stereochemical inversion at the 3′‐position and bioisosteric replacements at the sulfonium cationic center. In vitro α ‐glucosidase inhibition assays identified 20b , 20l , and 21b as potent inhibitors. In vivo, 20b (15.0 mg kg −1 ) reduced postprandial blood glucose levels in sucrose‐loaded mice by 40.6% (15 min), 49.5% (30 min), and 43.6% (60 min), surpassing acarbose (20.0 mg kg − 1 ). Molecular docking of 20b with the N‐terminal subunit of Maltase‐Glucoamylase ( nt MGAM) revealed an identical binding mode, where 3′‐stereoinversion induced π– π stacking between the benzylidene acetal phenyl ring and Phe450 and electrostatic interactions between the ortho‐nitro group and Asp203. Cytotoxicity assessments confirmed the favorable safety profile of selected compounds in normal cell lines. Enzyme kinetic studies demonstrated fully competitive inhibition of α ‐glucosidase by these sulfonium salts.

Subjects

MeSH terms (MEDLINE)

Glycoside Hydrolase Inhibitorsalpha-GlucosidasesDrug DesignSulfonium CompoundsOrganoselenium CompoundsBenzylidene CompoundsAnimalsMiceStructure-Activity RelationshipMolecular Docking SimulationHumansMolecular StructureDose-Response Relationship, Drug

Author keywords

Salaciaα‐glucosidase inhibitorselenonium saltsstereo‐inversionsulfonium salts

Substances

Glycoside Hydrolase Inhibitorsalpha-GlucosidasesSulfonium CompoundsOrganoselenium CompoundsBenzylidene Compounds

Authors and institutions

  • School of Medicinal Chemistry, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, 210009, P. R. China.
  • School of Traditional Chinese Pharmacy, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, 210009, P. R. China.
  • Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, 78712, USA.
  • School of Pharmacy, Kinki University, 3-4-1 Kowakae, Higashi-osaka, Osaka, 577-8502, Japan.

ORCID profiles: Weijia Xie

Funding

  • National Key R&D Program of China

Cite

APA

Li, Y., Zhou, J., Wu, X., Li, W., Wang, Z., Yang, J., Tanabe, G., Muraoka, O., & Xie, W. (2025). Design and Synthesis of Sulfonium and Selenonium Derivatives Bearing 3′,5′‐ O ‐Benzylidene Acetal Side Chains as Potent α ‐Glucosidase Inhibitors. ChemMedChem. https://doi.org/10.1002/cmdc.202500299

Vancouver

Li Y, Zhou J, Wu X, Li W, Wang Z, Yang J, et al. Design and Synthesis of Sulfonium and Selenonium Derivatives Bearing 3′,5′‐ O ‐Benzylidene Acetal Side Chains as Potent α ‐Glucosidase Inhibitors. ChemMedChem. 2025. doi:10.1002/cmdc.202500299

BibTeX
@article{Li2025,
  author = {Li, Yaojia and Zhou, Jiahui and Wu, Xiaoxing and Li, Wei and Wang, Zhe and Yang, Jianchen and Tanabe, Genzoh and Muraoka, Osamu and Xie, Weijia},
  title = {Design and Synthesis of Sulfonium and Selenonium Derivatives Bearing 3′,5′‐ O ‐Benzylidene Acetal Side Chains as Potent α ‐Glucosidase Inhibitors},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202500299}
}
Start for free →